These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30170089)

  • 41. The mysteries of prescription pricing in retail pharmacies.
    Berki SE; Richards JW; Weeks HA
    Med Care; 1977 Mar; 15(3):241-50. PubMed ID: 846238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.
    Flood D; Mathieu I; Chary A; García P; Rohloff P
    BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous versus exogenous generic reference pricing for pharmaceuticals.
    Antoñanzas F; Juárez-Castelló CA; Rodríguez-Ibeas R
    Int J Health Econ Manag; 2017 Dec; 17(4):413-432. PubMed ID: 28508248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generic dispensing and substitution in mail and retail pharmacies.
    Wosinska M; Huckman RS
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-409-16. PubMed ID: 15451951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in generic drug prices between the US and Canada.
    Gooi M; Bell CM
    Appl Health Econ Health Policy; 2008; 6(1):19-26. PubMed ID: 18774867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implementation of a $4 generic drug program in a 340B pharmacy.
    Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
    Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
    Ruley M; Belcher M; Sayre H; Coustasse A
    Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022.
    Nikpay S; McGlave CC; Bruno JP; Yang H; Watts E
    JAMA Health Forum; 2023 Aug; 4(8):e232139. PubMed ID: 37540525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can Walmart make us healthier? Prescription drug prices and health care utilization.
    Borrescio-Higa F
    J Health Econ; 2015 Dec; 44():37-53. PubMed ID: 26376457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reference pricing with endogenous generic entry.
    Brekke KR; Canta C; Straume OR
    J Health Econ; 2016 Dec; 50():312-329. PubMed ID: 27350294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Free antibiotic and vaccination programmes in community pharmacies of Miami-Dade County, FL, USA.
    Gauthier TP; Suda KJ; Mathur SK; Harriman D; Pham J; Aragon L; Abbo LM; Hooton TM
    J Antimicrob Chemother; 2015 Feb; 70(2):594-7. PubMed ID: 25331056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retail pharmacy market structure and performance.
    Brooks JM; Doucette WR; Wan S; Klepser DG
    Inquiry; 2008; 45(1):75-88. PubMed ID: 18524293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ontario's law curbing the cost of generic drugs sparks changes for pharmacies and other Canadian buyers.
    Silversides A
    CMAJ; 2009 Aug; 181(3-4):E43-5. PubMed ID: 19652155
    [No Abstract]   [Full Text] [Related]  

  • 56. Income differences between locations of 340B entities and contract pharmacies.
    Masia N; Kuwonza F
    Am J Manag Care; 2023 Jun; 29(6):e184-e188. PubMed ID: 37341983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generic substitution: micro evidence from register data in Norway.
    Dalen DM; Furu K; Locatelli M; Strøm S
    Eur J Health Econ; 2011 Feb; 12(1):49-59. PubMed ID: 20213182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medicare-approved drug discount cards and prescription drug prices.
    Chisholm MA; Turner JC; Dipiro JT
    Am J Health Syst Pharm; 2005 Jul; 62(14):1482-7. PubMed ID: 15998928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings].
    Wasserfallen JB; Shimia S; Biollaz J; Pannatier A
    Rev Med Suisse; 2006 Mar; 2(59):865-6, 868-71. PubMed ID: 16646370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
    Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
    J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.